Close



Nov 7, 2023 04:08PM
Nov 7, 2023 04:05PM
Aug 10, 2023 05:57AM
Aug 7, 2023 04:43PM
Aug 6, 2023 09:00PM
Jun 6, 2023 08:07AM
Jun 6, 2023 08:05AM Zai Lab and Novocure Announce LUNAR Phase 3 Clinical Trial Demonstrates Statistically Significant and Clinically Meaningful Extension in Overall Survival for Patients with Metastatic Non-Small Cell Lu
May 9, 2023 04:25PM
Apr 20, 2023 07:30AM
Mar 1, 2023 04:26PM
Mar 1, 2023 04:01PM
Feb 9, 2023 07:30AM
Jan 5, 2023 07:35AM
Jan 5, 2023 07:34AM Zai Lab and Novocure Announce Pivotal LUNAR Study in Non-Small Cell Lung Cancer Met Primary Overall Survival Endpoint
Nov 9, 2022 04:02PM
Nov 9, 2022 04:01PM
Oct 18, 2022 07:30AM
Aug 9, 2022 04:20PM
Aug 9, 2022 04:05PM
Jul 19, 2022 07:38AM
Jun 3, 2022 08:01AM Zai Lab Limited (ZLAB) and Novocure (NVCR) Report Phase 2 Study Evaluating Tumor Treating Fields Together with Standard-of-Care Chemotherapy Meets Primary Endpoint
Jun 3, 2022 08:00AM
Jun 3, 2022 08:00AM
May 10, 2022 04:01PM
Apr 20, 2022 07:30AM
Mar 3, 2022 07:37AM
Mar 3, 2022 07:30AM
Mar 1, 2022 04:05PM Zai Lab Announces Financial Results and Corporate Updates for Twelve Months Ended December 31, 2021
Feb 15, 2022 07:30AM
Nov 9, 2021 04:10PM
Nov 4, 2021 07:30AM
Oct 26, 2021 07:30AM
Oct 4, 2021 07:30AM
Oct 4, 2021 07:30AM
Aug 11, 2021 04:05PM Entasis Therapeutics Reports Second Quarter 2021 Financial Results and Provides Business Update
Aug 9, 2021 04:30PM
Jul 22, 2021 07:30AM
May 10, 2021 07:32AM
May 5, 2021 04:05PM
May 5, 2021 04:05PM
Apr 26, 2021 07:30AM
Apr 13, 2021 07:38AM Zai Lab (ZLAB) Partner Novocure Announces Update on Phase 3 Pivotal LUNAR Trial of Tumor Treating Fields in Non-Small Cell Lung Cancer, DMC Says Trial Should Continue
Apr 13, 2021 07:37AM
Mar 1, 2021 07:00AM
Feb 18, 2021 07:30AM
Aug 13, 2020 07:30AM
Aug 13, 2020 07:30AM
Aug 10, 2020 08:30AM
Aug 6, 2020 04:05PM Entasis Therapeutics Reports Second Quarter 2020 Financial Results and Business Update
Aug 6, 2020 04:04PM

940,637 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All